FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Court Rules Walgreens Must Face Most Claims in Generics Overcharging Class Action March 14, 2018 E&C Committee Puts Pressure on Three Major Drugmakers Regarding Opioid Crisis August 3, 2018 Nephron SC Warning Letter Cites Multiple Cross-Contamination Issues October 25, 2022